[1] A. H. Al-Shamiri, A. H. Al-Zubairy, and R. F. Al-Mamari, “The prevalence of Cryptosporidium spp. in children, Taiz District, Yemen,” Iran. J. Parasitol., vol. 5, no. 2, p. 26, 2010.
[2] K. M. Abdul-Sada, “Molecular and Epidemiological Study of Cryptosporidium spp. in Mid-Euphrates Area,” Kufa J. Nurs. Sci., vol. 5, no. 1, pp. 167–178, 2015.
[3] J. Arokiaraj, A. Mugunthan, and P. K. Gupta, “Interleukin types and its application,” Indian J. Allergy, Asthma Immunol., vol. 34, no. 2, pp. 57–62, 2020.
[4] M. N. Alkhanaq and G. T. Al-Hadidi, “Molecular study of Cryptosporidium spp. among diarrheal patients at Wasit province, Iraq,” AsPac J Mol Biol Biotechnol, vol. 30, pp. 24–31, 2022.
[5] N. L. Leech and A. J. Onwuegbuzie, “Beyond constant comparison qualitative data analysis: Using NVivo.,” Sch. Psychol. Q., vol. 26, no. 1, p. 70, 2011.
[6] O. T. Burton et al., “Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy,” Mucosal Immunol., vol. 6, no. 4, pp. 740–750, 2013.
[7] R. F. Daly and N. T. Hill, “Characterizing the Role of Animal Exposures in Cryptosporidiosis and Shiga Toxin‐producing Escherichia coli Infections: South Dakota, 2012,” Zoonoses Public Health, vol. 63, no. 6, pp. 467–476, 2016.
[8] A. A. Rahi, A. Magda, and A. H. Al-Charrakh, “Prevalence of Cryptosporidium parvum among children in Iraq,” Am. J. Life Sci., vol. 1, no. 6, pp. 256–260, 2013.
[9] C. Cruickshank-Quinn, L. K. Zheng, K. Quinn, R. Bowler, R. Reisdorph, and N. Reisdorph, “Impact of blood collection tubes and sample handling time on serum and plasma metabolome and lipidome,” Metabolites, vol. 8, no. 4, p. 88, 2018.
[10] M. Tanyuksel and W. A. Petri Jr, “Laboratory diagnosis of amebiasis,” Clin. Microbiol. Rev., vol. 16, no. 4, pp. 713–729, 2003.
[11] B. L. P. Ungar, R. H. Gilman, C. F. Lanata, and I. Perez-Schael, “Seroepidemiology of Cryptosporidium infection in two Latin American populations,” J. Infect. Dis., vol. 157, no. 3, pp. 551–556, 1988.
[12] A. Samie, R. L. Guerrant, L. Barrett, P. O. Bessong, E. O. Igumbor, and C. L. Obi, “Prevalence of intestinal parasitic and bacterial pathogens in diarrhoeal and non-diarroeal human stools from Vhembe district, South Africa,” J. Health. Popul. Nutr., vol. 27, no. 6, p. 739, 2009.
[13] N. K. Mahdi, I. Al Sadoon, and A. T. Mohamed, “First report of cryptosporidiosis among Iraqi children,” EMHJ-Eastern Mediterr. Heal. Journal, 2 (1), 115-120, 1996, 1996.
[14] M. Salim, “Epidemiological study on Cryptosporidium among children in Basra Province-Iraq,” in Journal of Physics: Conference Series, 2018, vol. 1032, no. 1, p. 12072.
[15] Q. M. Koyee and A. M. Faraj, “Prevalence of Cryptosporidium spp. with other intestinal microorganisms among regular visitors of Raparin Pediatric Hospital in Erbil City-Kurdistan region, Iraq,” Zanco J. Pure Appl. Sci., vol. 27, no. 4, pp. 57–64, 2015.
[16] N. K. Mahdi and N. H. Ali, “Intestinal parasites, including Cryptosporidium species, in Iraqi patients with sickle-cell anaemia,” EMHJ-Eastern Mediterr. Heal. Journal, 8 (2-3), 345-349, 2002, 2002.
[17] T. Wegayehu, H. Adamu, and B. Petros, “Prevalence of Giardia duodenalis and Cryptosporidium species infections among children and cattle in North Shewa Zone, Ethiopia,” BMC Infect. Dis., vol. 13, pp. 1–7, 2013.
[18] T. Geurden et al., “Multilocus genotyping of Cryptosporidium and Giardia in non-outbreak related cases of diarrhoea in human patients in Belgium,” Parasitology, vol. 136, no. 10, pp. 1161–1168, 2009.
[19] S. Sallon, R. J. Deckelbaum, I. I. Schmid, S. Harlap, M. Baras, and D. T. Spira, “Cryptosporidium, malnutrition, and chronic diarrhea in children,” Am. J. Dis. Child., vol. 142, no. 3, pp. 312–315, 1988.
[20] K. Nagamani, P. R. R. Pavuluri, M. Gyaneshwari, K. Prasanthi, M. I. S. Rao, and N. K. Saxena, “Molecular characterisation of Cryptosporidium: an emerging parasite,” Indian J. Med. Microbiol., vol. 25, no. 2, pp. 133–136, 2007.
[21] T. A. A. Mourad, “Palestinian refugee conditions associated with intestinal parasites and diarrhoea: Nuseirat refugee camp as a case study,” Public Health, vol. 118, no. 2, pp. 131–142, 2004.
[22] S. M. Abu-Alrub, G. M. Abusada, M. A. Farraj, and T. A. Essawi, “Prevalence of Cryptosporidium spp. in children with diarrhoea in the West Bank, Palestine,” J. Infect. Dev. Ctries., vol. 2, no. 01, pp. 59–62, 2008.
[23] B. Szonyi, R. Bordonaro, S. E. Wade, and H. O. Mohammed, “Seasonal variation in the prevalence and molecular epidemiology of Cryptosporidium infection in dairy cattle in the New York City Watershed,” Parasitol. Res., vol. 107, pp. 317–325, 2010.
[24] Y. Jiang et al., “Cryptosporidium andersoni as a novel predominant Cryptosporidium species in outpatients with diarrhea in Jiangsu Province, China,” BMC Infect. Dis., vol. 14, no. 1, pp. 1–6, 2014.
[25] M. Ceyhan et al., “Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005–2006: a hospital-based study,” J. Infect. Dis., vol. 200, no. Supplement_1, pp. S234–S238, 2009.
[26] B. Bedi, N. N. McNair, I. Förster, and J. R. Mead, “IL‐18 cytokine levels modulate innate immune responses and cryptosporidiosis in mice,” J. Eukaryot. Microbiol., vol. 62, no. 1, pp. 44–50, 2015.
[27] R. C. G. Pollok, M. J. G. Farthing, M. Bajaj-Elliott, I. R. Sanderson, and V. McDonald, “Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum,” Gastroenterology, vol. 120, no. 1, pp. 99–107, 2001.
[28] M. H. Zaki, K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T.-D. Kanneganti, “The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis,” Immunity, vol. 32, no. 3, pp. 379–391, 2010.
[29] P. N. Campbell and W. L. Current, “Demonstration of serum antibodies to Cryptosporidium sp. in normal and immunodeficient humans with confirmed infections,” J. Clin. Microbiol., vol. 18, no. 1, pp. 165–169, 1983.
[30] Z. Liu, H. Wang, W. Xiao, C. Wang, G. Liu, and T. Hong, “Thyrocyte interleukin‐18 expression is up‐regulated by interferon‐γ and may contribute to thyroid destruction in Hashimoto’s thyroiditis,” Int. J. Exp. Pathol., vol. 91, no. 5, pp. 420–425, 2010.